Home / Research and experimental development on biotechnology (except medical and veterinary science)

CELL COIN PTE. LTD.

Live CompanyUEN 202503691HLocal Company

CELL COIN PTE. LTD. is a local company in Singapore with UEN 202503691H. It was registered on 20 Jan 2025, 1 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202503691H
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered20 Jan 2025
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity74902 Brokerage and consultancy services of intellectual property assets
Address139 CECIL STREET, #03-20, YSY BUILDING, Singapore 069539
280 companies at this address
AreaDowntown Core · District 1 (Raffles Place, Cecil, Marina, People's Park)
Nearest stationShenton Way MRT, about 230 m
Officers7
Last annual return31 Jul 2026

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.